David Awad

1 week ago | ajmc.com | Laura Joszt |Hayden E. Klein |David Awad

Captions were auto-generated. As value-based care models expand across the oncology landscape, pharmacists play a growing role in navigating the complex intersection of therapeutic innovation, fiscal responsibility, and patient access. In an interview with The American Journal of Managed Care®(AJMC®),David Awad, PharmD, BCOP, oncology pharmacy manager at Robert Wood Johnson University Hospital, described the balancing act pharmacy teams must perform in the current treatment landscape.

2 weeks ago | ajmc.com | Laura Joszt |Hayden E. Klein |David Awad

David Awad, PharmD, BCOP, oncology pharmacy manager, Robert Wood Johnson University Hospital, emphasizes the importance of documentation and communication in supporting seamless collaboration between pharmacists and oncology providers. By tracking medication-related interventions and maintaining transparency across cycles of therapy, he says pharmacists can help ensure patients can safely continue beneficial treatments while avoiding unnecessary drug holds or changes.

3 weeks ago | ajmc.com | Laura Joszt |Hayden E. Klein |David Awad

As chimeric antigen receptor (CAR) T-cell and bispecific therapies become more widely available, pharmacists are essential in navigating patient-specific complexities, insurance approvals, and more. According to David Awad, PharmD, BCOP, oncology pharmacy manager, Robert Wood Johnson University Hospital, their expertise in evaluating toxicities, managing adverse effects, and conducting comprehensive medication reviews supports safer, more effective cancer care within value-based models.